Mankind Pharma Ltd. · MANKIND
The daily read · from the close of 6 Oct
That day's whole fieldrank 403 of 856
Nifty in 10 sessions
In the middle of the field
+4.9% over 30 sessions · +8.0% vs Nifty over 90 · -4.1% vs its sector · 81% of its 52-week range · delivery rising. Layer percentiles across the field: L2 momentum 88.6, L3 vs market 89.8, L4 vs sector 39.6, L5 own record 40.5. The references are its own median ten-session rise and fall over the past year — arithmetic on its own history, not a price goal.
Its daily score over the last 60 sessions, oldest to newest; green when it sat in the top fifth, red in the bottom fifth. Of the 49 judged, 19 went the way its half of the field leaned.
How it has moved
All performers| Window | Move | vs Nifty | vs sector | vs itself | How it moved | Rank | |
|---|---|---|---|---|---|---|---|
| Week28 Sep on · 6 sessions | +1.0% | +2.6% | +2.7% | 67th pct | 3 of 6 up | 173 of 856 | |
| Month1 Sep on · 24 sessions | +3.3% | +8.8% | +5.7% | 72th pct | 11 of 24 up | 167 of 856 | |
| Quarter7 Jul on · 64 sessions | -1.6% | +5.1% | -4.3% | 56th pct | 28 of 64 up | 369 of 856 | |
| Half year7 Apr on · 125 sessions | +23.9% | +24.7% | +2.3% | 97th pct | 61 of 125 up | 321 of 855 | Stretched |
| Year7 Oct on · 246 sessions | +1.8% | +11.0% | -20.1% | 91th pct | 112 of 246 up | 376 of 855 |
The read
made on the morning of 25 Jul 2026 for Q1FY27Favourable — second fifth of the companies reporting that week: rank 55 of 233, composite 69.3 out of 100. Moves 3.7% on results on average; has decoupled from the index while rising, leads its sector.
Across every post-mortem on this site, companies read favourable went up over the next ten sessions — the way the label points — in 336 of 1073 (31%), averaging -0.8% against the market. Track record
How it went: went against the read -6.1% vs market over the ten sessions after 30 Jul 2026 — the post-mortem is further down.
A read is a position on a screen, not advice. The label says where the composite ranked, the tally says how often that has gone the way it pointed, and the choice is the reader's.
The read · morning of 25 Jul 2026
for Q1FY27 on 30 Jul 2026Moves 3.7% on results on average; has decoupled from the index while rising, leads its sector.
Each layer is a percentile among this week's reporters (0–100). A missing layer's weight is spread over the others.
Composite = 0.30 × 48.5 + 0.20 × 67.9 + 0.30 × 84.5 + 0.20 × 78.9 = 69.3
Reactivity
Over the last 13 results the average absolute move from the session before the announcement to the session after was 3.7%. The largest was 8.1% (Q1FY24). Historically the pre-result 30-day trend continued through the announcement in 75% of classified quarters.
- Typical move (T-1 → T+1)
- 3.7%
- Median move
- 3.4%
- Biggest
- +8.1% (Q1FY24)
- Up after 10 sessions
- 38% of 13
- Mean 10-session return
- +1.7%
- Mean 10-session vs market
- +1.4%
- Volume on result day
- 3.7× normal
- Pattern
- Continuation
Going in
Up 5.7% over 30 sessions and 11.7% over 90 sessions. Sitting at the 76th percentile of its 52-week range. Closed above its 20-day average on 80% of the last 30 sessions.
Normally tracks NIFTY 50 at a correlation of 0.24; over the last 30 sessions that has run at -0.01 (1.5 standard deviations from its own norm). Over 30 sessions it has outrun what its beta of 0.52 to the index would account for, by 4.3 percentage points. The move is the stock's own rather than the market's.
Over 90 sessions it has outperformed NIFTY PHARMA by 2.3 percentage points, and led it over the last 30 by 0.6. Strength is showing against both the market and its own pack.
Where it sits
Beats market and sector over 90 sessions: +12.2% against the market, +2.3% against NIFTY PHARMA. Up and right is ahead of both; down and left is behind both.
Numbers behind the scores
- Share of reactions upward
- 54%
- Continuation ratio
- 75%
- Move spread (SD)
- 2.5%
- Average gap at open
- +1.24%
- 30-session return
- +5.7%
- 90-session return
- +11.7%
- Since last result
- -3.0% (45 sessions)
- 20-DMA vs 50-DMA
- +2.5%
- Sessions above 20-DMA
- 80%
- Position in 52-week range
- 76%
- Delivery, 30 / 90 sessions
- 51.9% / 52.2%
- Delivery trend
- -0.3 pp
- Benchmark
- NIFTY 50
- Correlation, 30 sessions / norm
- -0.01 / 0.25
- Correlation break
- 1.53 SD
- Beta, 30 / 90 sessions
- -0.02 / 0.58
- Alpha, 30 sessions
- +4.3%
- Market regime
- idiosyncratic accumulation
- Sector index
- NIFTY PHARMA
- vs sector, 30 / 90 sessions
- +0.6% / +2.3%
- Sector correlation / norm
- 0.76 / 0.36
- Quadrant score
- 100
- Evidence
- full · 13 results used
- Price band
- bluechip
What its results record says
14 results · ten sessions after each · from the close before the resultThis is the range each past result travelled, on closing prices. It is a description of the past, not a level for the next one, and this site gives no entry, exit or loss-limit levels.
Last 90 sessions
daily candles · adjusted for splits and bonuses · test patterns → · the outlook for the coming hours and days → · week by week: slope, patterns, next four weeks →Against the market and its sector
same 90 sessions · every line starts at 0%Around the last result · Q1FY27
ten sessions in, the result day, ten sessions out · from the close before the resultTen sessions after each result
share vs market vs sector · move from the close before the resultResults record
move from the close before each result| Quarter | Result day | Gap | T+1 | T+10 | Market T+10 | vs market | vs sector | Vol × | Result |
|---|---|---|---|---|---|---|---|---|---|
| Q1FY27 | 31 Jul 2026 | +1.1% | -3.6% | -5.9% | +0.2% | -6.1% | -6.2% | 6.5 | Rev 13% · PAT 29% YoY |
| Q4FY26 | 20 May 2026 | +0.3% | +0.9% | -4.9% | -0.9% | -4.0% | -1.8% | 7.5 | — |
| Q3FY26 | 4 Feb 2026 | +1.7% | -3.8% | -4.0% | +0.4% | -4.4% | -5.6% | 2.3 | Rev 10% · PAT 8% YoY |
| Q2FY26 | 7 Nov 2025 | -2.6% | -3.1% | -2.9% | +2.2% | -5.1% | -4.4% | 3.0 | Rev 20% · PAT -21% YoY |
| Q1FY26 | 1 Aug 2025 | +0.1% | +2.4% | -3.7% | +0.4% | -4.1% | -0.9% | 0.7 | Rev 23% · PAT -18% YoY |
| Q4FY25 | 22 May 2025 | -3.2% | -3.9% | -6.8% | -0.3% | -6.6% | -6.4% | 2.9 | — |
| Q3FY25 | 24 Jan 2025 | -2.8% | -6.9% | -4.4% | +1.5% | -5.9% | -3.2% | 3.0 | — |
| Q2FY25 | 6 Nov 2024 | +5.9% | +0.5% | -5.7% | -3.6% | -2.2% | -1.7% | 6.6 | — |
| Q1FY25 | 1 Aug 2024 | +0.5% | -1.4% | +13.5% | -1.6% | +15.1% | +11.9% | 2.7 | — |
| Q4FY24 | 16 May 2024 | +4.1% | -4.6% | -2.3% | +1.5% | -3.8% | -1.9% | 8.4 | — |
| Q3FY24 | 1 Feb 2024 | +3.1% | +1.8% | +10.6% | +0.9% | +9.7% | +7.1% | 3.0 | — |
| Q2FY24 | 1 Nov 2023 | -0.7% | +3.4% | +6.9% | +3.1% | +3.8% | +1.3% | 2.3 | — |
| Q1FY24 | 3 Aug 2023 | +9.2% | +8.1% | +6.2% | -1.1% | +7.3% | +4.0% | 5.9 | — |
| Q4FY23 | 1 Jun 2023 | +0.6% | +7.8% | +19.2% | +1.2% | +18.0% | +16.8% | 0.2 | — |
Reported figures
₹ crore; from the exchange's XBRL filings| Quarter | Period end | Revenue | YoY | PAT | YoY | Op. margin | EPS |
|---|---|---|---|---|---|---|---|
| Q1FY27 | 30 Jun 2026 | 4,030 | +12.9% | 574 | +29.1% | 26.2% | 13.76 |
| Q4FY26 | 31 Mar 2026 | 3,442 | — | 559 | — | 26.3% | 13.44 |
| Q3FY26 | 31 Dec 2025 | 3,567 | +10.4% | 413 | +7.6% | 22.8% | 9.90 |
| Q2FY26 | 30 Sep 2025 | 3,697 | +20.2% | 520 | -21.1% | 24.9% | 12.39 |
| Q1FY26 | 30 Jun 2025 | 3,570 | +23.4% | 444 | -18.1% | 23.7% | 10.62 |
| Q3FY25 | 31 Dec 2024 | 3,230 | — | 384 | — | 25.7% | 9.45 |
| Q2FY25 | 30 Sep 2024 | 3,076 | — | 658 | — | 27.6% | 16.31 |
| Q1FY25 | 30 Jun 2024 | 2,893 | — | 543 | — | 23.6% | 13.39 |
| Q4FY24 | 31 Mar 2024 | 2,441 | — | 476 | — | 24.2% | 11.76 |
| Q3FY24 | 31 Dec 2023 | 2,606 | — | 459 | — | 23.3% | 11.33 |
| Q2FY24 | 30 Sep 2023 | 2,708 | — | 511 | — | 25.2% | 12.51 |
| Q1FY24 | 30 Jun 2023 | 2,578 | — | 494 | — | 25.4% | 12.15 |
Post-mortems
Every result in full →- No reported figures on file for this quarter, so the result itself could not be judged.
- Its usual continuation pattern did not hold this quarter.
- 5 sector peers reported the same week; the sector read may already have been set.
- Ran up 25% in the 30 sessions before the result — a good number had little left to reward.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Its continuation habit held this quarter.
- 4 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Its continuation habit held this quarter.
- 11 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 4 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 5 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Announced during market hours, so the reaction session is the announcement day itself.
- 3 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- The market itself moved -3.6% over the same ten sessions; the raw move is mostly tide.
- Its sector moved -4.1% over the window.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- 3 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Volume ran 1.6x its prior month in the fortnight before.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Delivery share rose 6 points in the fortnight before — someone was taking stock home.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Delivery share rose 9 points in the fortnight before — someone was taking stock home.
- 5 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- The market itself moved +3.1% over the same ten sessions; the raw move is mostly tide.
- Its sector moved +5.7% over the window.
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.